Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: A network meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 7, 2013, Pages 778-783

  Akbar, Ali ^a   Abu Dayyeh, Barham K ^a   Baron, Todd H ^a   Wang, Zhen ^a   Altayar, Osama ^a   Murad, Mohammad Hassan ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adverse Event Complication; Pancreatic Inflammation; Prevention; Treatment

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

COMPARATIVE EFFECTIVENESS; DIGESTIVE STENT; EMBASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MEDLINE; META ANALYSIS; PANCREATITIS; REVIEW; SYSTEMATIC REVIEW;

ADMINISTRATION, RECTAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOPREVENTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATIC DUCTS; PANCREATITIS; STENTS; TREATMENT OUTCOME;

EID: 84879238030     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.043     Document Type: Review

References (49)

1. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996, 335:909-918.
2. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37:383-393.
3. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998, 48:1-10.
4. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002, 34:280-285.
5. Freeman M.L., Overby C., Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004, 59:8-14.
6. Sofuni A., Maguchi H., Mukai T., et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol 2011, 9:851-858.
7. Bakman Y.G., Safdar K., Freeman M.L. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009, 41:1095-1098.
8. Elmunzer B.J., Waljee A.K., Elta G.H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008, 57:1262-1267.
9. Baron T.H., Abu Dayyeh B.K., Zinsmeister A.R., et al. Rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012, 367:277-278.
10. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
11. Schoenfeld P., Cook D., Hamilton F., et al. An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group. Gastroenterology 1998, 114:1318-1325.
12. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
13. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002, 21:2313-2324.
14. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
15. Sterne J.A., Egger M., Smith G.D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001, 323:101-105.
16. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012, 366:1414-1422.
17. Ioannidis J.P., Trikalinos T.A. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007, 176:1091-1096.
18. Das A., Singh P., Sivak M.V., et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007, 65:960-968.
19. Chen C.C., Wang S.S., Lu R.H., et al. Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography. Pancreas 2003, 26:375-380.
20. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 2004, 60:544-550.
21. Andriulli A., Forlano R., Napolitano G., et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007, 75:156-163.
22. Mazaki T., Masuda H., Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010, 42:842-853.
23. Dumonceau J.M., Rigaux J., Kahaleh M., et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc 2010, 71:934-939.
24. Katsinelos P., Fasoulas K., Paroutoglou G., et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy 2012, 44:53-59.
25. Sotoudehmanesh R., Khatibian M., Kolahdoozan S., et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007, 102:978-983.
26. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993, 39:652-657.
27. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998, 115:1518-1524.
28. Elton E., Howell D.A., Parsons W.G., et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998, 47:240-249.
29. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999, 49:322-327.
30. Aizawa T., Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001, 54:209-213.
31. Norton I.D., Gostout C.J., Baron T.H., et al. Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 2002, 56:239-243.
32. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc 2003, 57:291-294.
33. Catalano M.F., Linder J.D., Chak A., et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004, 59:225-232.
34. Harewood G.C., Pochron N.L., Gostout C.J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005, 62:367-370.
35. Hookey L.C., RioTinto R., Delhaye M., et al. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases. Endoscopy 2006, 38:670-676.
36. Sofuni A., Maguchi H., Itoi T., et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007, 5:1339-1346.
37. Tsuchiya T., Itoi T., Sofuni A., et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. J Hepato Biliary Pancreat Surg 2007, 14:302-307.
38. Saad A.M., Fogel E.L., McHenry L., et al. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc 2008, 67:255-261.
39. Madácsy L., Kurucsai G., Fejes R., et al. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis. Dig Endosc 2009, 21:8-13.
40. Ito K., Fujita N., Noda Y., et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation?. A prospective randomized controlled trial. J Gastroenterol 2010, 45:1183-1191.
41. Pan X.P., Dang T., Meng X.M., et al. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting. Cell Biochem Biophys 2011, 61:473-479.
42. Sakai Y., Tsuyuguchi T., Mikata R., et al. Utility of placement of pancreatic duct spontaneous dislodgement stent for prevention of post-ERCP pancreatitis in patients with difficulty in selective biliary cannulation. Hepatogastroenterology 2011, 58:687-693.
43. Zhou W., Li Y., Zhang Q., et al. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases. Pancreatology 2011, 11:399-405.
44. Kawaguchi Y., Ogawa M., Omata F., et al. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2012, 18:1635-1641.
45. Lee T.H., Moon J.H., Choi H.J., et al. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Gastrointest Endosc 2012, 76:578-585.
46. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124:1786-1791.
47. Khoshbaten M., Khorram H., Madad L., et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 2008, 23:e11-e16.
48. Montaño Loza A., Rodríguez Lomelí X., García Correa J.E., et al. [Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes]. Rev Esp Enferm Dig 2007, 99:330-336.
49. Otsuka T., Kawazoe S., Nakashita S., et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol 2012, 47:912-917.